On August 10, Doximity, Inc. declined 8.97% in regular trading, trading at $24.81/share, with turnover of $26.61 million. The stock continued to retreat from the massive AI-driven rally earlier this week, as investors reassessed fundamentals against the euphoric reaction.

On August 7, Doximity shares had surged as much as 200% in pre-market after CEO Jeff Donnie highlighted the company's clinical AI strategy as a once-in-a-generation opportunity during the earnings call. The company's AI search and transcription tools saw usage growth, with transcription note users increasing 10x year-over-year in July. However, the underlying quarterly results missed Wall Street expectations, with adjusted EPS of $0.29 versus the consensus estimate of $0.31, and revenue of $156.6 million representing only 7% year-over-year growth. Adjusted EPS had already declined 31.58% in the prior quarter, signaling persistent profit pressure.

The current pullback suggests the market is recalibrating expectations as the initial AI enthusiasm fades and attention returns to the gap between narrative momentum and near-term financial performance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)